(Alliance News) - Tristel PLC on Monday posted a surge in annual profit and said its outlook was the strongest it has been in its 30-year history. Read More
(Alliance News) - Tristel PLC on Monday said it submitted its application to Health Canada to approve Tristel ULT as a class 2 medical device for endocavity ultrasound probes and skin surface transducers. Read More
Tristel PLC - Cambridgeshire-based maker of infection prevention products - Chief Executive Officer Paul Swinney sells 100,000 shares at 350 pence each, worth GBP350,000, in London on Thursday. Swinney is now interested in 312,350 shares, a 0.66% stake. Read More
(Alliance News) - Stock prices in London were higher at midday on Monday as markets looked to further positive news for the UK's service sector. Read More
(Alliance News) - Tristel PLC on Monday said it was granted approval from the US Food & Drug Administration for its ultrasound disinfectant for immediate sale. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - Tristel PLC on Monday reported that it swung to an interim profit in the six months to December 31, as its disinfectant foam De Novo could be approved by the US Food & Drug Administration. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued since last week Thursday and not separately reported by Alliance News: Read More
Tristel PLC - Cambridgeshire-based maker of infection prevention, contamination control and hygiene products - Chief Executive Officer Paul Swinney sells 300,000 shares at 333 pence each, worth GBP999,000, in London on Friday. Swinney now interested in 412,350 shares, a 0.9% stake. Read More
(Alliance News) - Tristel PLC on Monday posted a special dividend as it expects its annual profit and revenue to meet expectations, boosted by hospitals buying more disinfectants as more procedures are carried out. Read More
